BNP Paribas Financial Markets’s Vivani Medical VANI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-1
Closed -$16 4498
2019
Q3
$16 Hold
1
﹤0.01% 4477
2019
Q2
$15 Hold
1
﹤0.01% 4506
2019
Q1
$15 Buy
+1
New +$19 ﹤0.01% 4250
2018
Q4
Hold
0
4291
2018
Q3
Hold
0
4401
2018
Q2
Hold
0
4380
2018
Q1
Hold
0
4178
2017
Q4
Sell
-18,594
Closed -$618K 4176
2017
Q3
$156K Hold
18,594
﹤0.01% 2574
2017
Q2
$174K Sell
18,594
-10,417
-36% -$295K ﹤0.01% 2534
2017
Q1
$258K Buy
29,011
+29,008
+966,933% +$1.11M ﹤0.01% 2104
2016
Q4
$140 Sell
3
-37
-93% -$2.11K ﹤0.01% 4099
2016
Q3
$3.38K Buy
40
+17
+74% +$1.5K ﹤0.01% 3434
2016
Q2
$1.99K Buy
23
+17
+283% +$1.77K ﹤0.01% 3449
2016
Q1
$739 Sell
6
-75
-93% -$8.63K ﹤0.01% 2532
2015
Q4
$11.4K Sell
81
-38
-32% -$5.56K ﹤0.01% 3186
2015
Q3
$17K Buy
119
+78
+190% +$21.7K ﹤0.01% 3342
2015
Q2
$13.4K Buy
41
+35
+583% +$11.2K ﹤0.01% 3251
2015
Q1
$1.86K Buy
+6
New +$1.67K ﹤0.01% 3484

Other funds holding VANI

BNP Paribas Financial Markets's VANI Position: Q4 2019 in Review

BNP Paribas Financial Markets sold out of Vivani Medical (VANI) in Q4 2019, closing a stake of 1 share — an estimated $16 sold.

BNP Paribas Financial Markets first reported a position in VANI in Q1 2015 and held it in 14 quarters. The position peaked at $258K in Q1 2017. 30 funds tracked by Wall St. Rank hold VANI as of Q4 2019.

  • BNP Paribas Financial Markets reported no remaining Vivani Medical position as of Q4 2019 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 1 Vivani Medical share in Q4 2019, an estimated $16.
  • BNP Paribas Financial Markets first reported a position in Vivani Medical in Q1 2015 and held it in 14 quarters.
  • BNP Paribas Financial Markets's Vivani Medical position peaked at $258K in Q1 2017.
  • 30 funds tracked by Wall St. Rank held Vivani Medical as of Q4 2019.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2019, filed 12 Feb 2020.